Intended for healthcare professionals


Sixty seconds on . . . prostate cancer

BMJ 2018; 360 doi: (Published 27 March 2018) Cite this as: BMJ 2018;360:k1385
  1. Nigel Hawkes
  1. London

What’s the latest take? Operate or watchful wait?

As reluctant as surgeons are to do nothing, an important trial published last year put a crimp in their confidence. PIVOT followed 731 men with early prostate cancer who were randomised to prostatectomy or observation and followed up for almost 20 years. It found that surgery didn’t lead to lower mortality from all causes or from prostate cancer.1

So, lots of men risked impotence or incontinence for nothing?

That’s …

View Full Text

Log in

Log in through your institution


* For online subscription